US-based Neuro-Horizon Pharma licenses promising compounds from NTU Singapore to combat multidrug-resistant tuberculosis
With multidrug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments are urgently required to tackle this ...